Apsara Therapeutics
-
2012
Company Description
Apsara Therapeutics develops antibody therapies for the treatment of neuromyelitis optica.
Apsara Therapeutics develops antibody therapies for the treatment of neuromyelitis optica, a demyelinating disorder characterized by the formation of lesions on the spinal cord and the optic nerve. Its therapies block NMO lesion formation and halt the inflammatory cascade that often results in demyelination and neuronal cell death. Apsara Therapeutics is based in Houston, Texas.
-
Manufacturer:
Science and Engineering -
Formed:
2012 -
Founders:
Dan Janiak -
Company Website:
-
Company E-mail:
-
Company Address:
One Greenway Plaza, Suite 930Houston, TXUnited States -
CEO:
- Dan Janiak
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits